Organization

Beaumont Health

7 abstracts

Abstract
Venous thromboembolism prophylaxis during neoadjuvant chemotherapy for patients with ovarian cancer.
Org: University of Michigan Hospital, University of Michigan, Beaumont Health, Michigan Medicine, Rogel Cancer Center, University of Michigan, Ann Arbor, MI,
Abstract
African American women who carry the BRCA1/2 mutation: Clinical characteristics and prevention strategies.
Org: Corewell Health System - Beaumont University Hospital, William Beaumont University Hospital, Beaumont Health, Oakland University William Beaumont Medical School,
Abstract
Cancer risk and characteristics in older female BRCA1/2 mutation carriers.
Org: Corewell Health System - Beaumont University Hospital, William Beaumont University Hospital, Beaumont Health, Oakland University William Beaumont Medical School,
Abstract
Role of HLA-DRB4 as a biomarker for endocrine toxicity and survival outcomes after immunotherapy in metastatic non-small cell lung cancer.
Org: University of Michigan, Fred Hutchinson Cancer Research Center, Beaumont Health, University of Michigan Health Management Research Center, Fred Hutchinson Cancer Center/Division of Hematology and Oncology,
Abstract
Evaluating disparities in pancreatic cancer outcomes in African Americans.
Org: Corewell Health System - Beaumont University Hospital, William Beaumont University Hospital, Beaumont Health, Oakland University William Beaumont Medical School, William Beaumont Medical School,
Abstract
A phase II trial of pevonedistat plus docetaxel in patients with previously treated advanced non–small-cell lung cancer (NSCLC).
Org: University of Michigan, University of Michigan, Rogel Cancer Center, Henry Ford Cancer Institute, Detroit, MI, Michigan Medicine, Rogel Cancer Center, University of Michigan, Ann Arbor, MI, University of Michigan Health System Comprehensive Cancer Center,